Increasing human monoclonal antibody cloning efficiency with a whole-cell modified immunoglobulin-capture assay (mICA). (2023)
Attributed to:
Development of a cost-effective protein-based combined glycoconjugate meningococcal-pneumococcal vaccine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2023.1184510
PubMed Identifier: 37334357
Publication URI: http://europepmc.org/abstract/MED/37334357
Type: Journal Article/Review
Volume: 14
Parent Publication: Frontiers in immunology
ISSN: 1664-3224